NRX Pharmaceuticals, Inc.

Big Rock Partners Acquisition Corp, trading under the ticker BRPA, was a blank-check company sponsored by Big Rock Partners LLC that completed its initial public offering in 2018 targeting the healthcare and biopharmaceutical sector. The SPAC filed a Form 10-Q with the SEC on November 8, 2018, under accession number 0001654954-18-012244, reflecting its status during the search and evaluation phase of its lifecycle. BRPA ultimately completed a business combination with NRX Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on central nervous system and respiratory conditions. For full filing history, deal terms, and sponsor details on BRPA and thousands of other SPACs, sign up for a SpacDesk account at SpacDesk.com.